Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
McKesson
Medtronic
McKinsey
Merck

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Litigation Details for Aptalis Pharmatech Inc. v. Apotex Inc. (D. Del. 2014)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Aptalis Pharmatech Inc. v. Apotex Inc. (D. Del. 2014)

Docket   Start Trial Date Filed 2014-08-11
Court District Court, D. Delaware Date Terminated 2016-12-08
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To Judge Sherry R. Fallon
Parties APOTEX CORP.; APOTEX INC.; APTALIS PHARMATECH INC.; IVAX INTERNATIONAL GMBH
Patents 4,839,177; 7,387,793; 7,790,199; 7,829,121
Attorneys Douglas Edward McCann; John C. Phillips , Jr.; Robert M. Oakes; Susan Morrison Coletti
Link to Docket External link to docket
Small Molecule Drugs cited in Aptalis Pharmatech Inc. v. Apotex Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Aptalis Pharmatech Inc. v. Apotex Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-08-11 1 United States Patent Nos. 7,790,199 (“the ’199 patent”) and 7,829,121 (“the ’121 patent”) (collectively… This is an action for patent infringement under the Food and Drug and Patent Laws of the United States…companies to submit patent information to FDA “with respect to which a claim of patent infringement could…interest in and to the ’199 patent. A true and correct copy of the ’199 patent is attached hereto as Exhibit…interest in and to the ’121 patent. A true and correct copy of the ’121 patent is attached hereto as Exhibit External link to document
2016-12-08 111 as anticipated by U.S. Patent No. 4,839, 177 ("the '177 patent"). According to the … analyzed whether certain patents (parent patents to the current patents-in-suit) were invalid for obviousness…alleging infringement of U.S. Patent Nos. 7,790,199 ("the '199 patent") and 7,829,121 ("… 1. The patents-in-suit The '199 patent issued on September 7, 2010…Relaxants" (collectively, "the patents-in-suit"). The patents-in-suit share a common specification External link to document
2016-12-08 114 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,790,199; 7,829,121. (Attachments… 8 December 2016 1:14-cv-01038-SLR-SRF Patent None District Court, D. Delaware External link to document
2014-08-11 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,790,199; US 7,829,121;. (… 8 December 2016 1:14-cv-01038-SLR-SRF Patent None District Court, D. Delaware External link to document
2015-06-18 81 disputed claim language of U.S. Patent Nos. 7,790,199 ("the '199 patent") 1 and 7, 829, 121 (…references are to the '199 patent. 2 Found in each claim of the patents-in-suit: "[A]n extended… ("the '121 patent") shall be construed consistent with the tenets of claim construction… 8 December 2016 1:14-cv-01038-SLR-SRF Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Baxter
Merck
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.